DaVita Inc. (DVA) is a leading provider of dialysis services in the U.S., specializing in care for patients with chronic kidney failure, also known as end-stage renal disease (ESRD). With a market cap of $14.2 billion, the company operates numerous dialysis centers and offers a variety of related medical services. Companies valued at $10 billion or more are generally considered “large-cap” stocks, and DaVita fits this criterion perfectly. DaVita is renowned for its extensive network of outpatient and inpatient dialysis centers and its strong focus on integrated care and disease management serv…